Q3 2018 13F Holders as of 9/30/2018
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
309M
-
Number of holders
-
194
-
Total 13F shares, excl. options
-
225M
-
Shares change
-
+4.6M
-
Total reported value, excl. options
-
$2.72B
-
Value change
-
+$35.8M
-
Put/Call ratio
-
0.15
-
Number of buys
-
106
-
Number of sells
-
-79
-
Price
-
$12.09
Significant Holders of AMICUS THERAPEUTICS, INC. - Common Stock, par value $0.01 per share (FOLD) as of Q3 2018
240 filings reported holding FOLD - AMICUS THERAPEUTICS, INC. - Common Stock, par value $0.01 per share as of Q3 2018.
AMICUS THERAPEUTICS, INC. - Common Stock, par value $0.01 per share (FOLD) has 194 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 225M shares
of 309M outstanding shares and own 73.04% of the company stock.
Largest 10 shareholders include PERCEPTIVE ADVISORS LLC (20.7M shares), Vanguard Group Inc (16.8M shares), BlackRock Inc. (16.4M shares), FMR LLC (13.5M shares), JENNISON ASSOCIATES LLC (10.1M shares), STATE STREET CORP (9.49M shares), venBio Select Advisor LLC (9.33M shares), JANUS HENDERSON GROUP PLC (8.81M shares), Redmile Group, LLC (8.4M shares), and WELLINGTON MANAGEMENT GROUP LLP (7M shares).
This table shows the top 194 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.